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Cryo-EM at Jefferson:
Driving a New Era of
Scientific Discovery
Scientific discovery is often the product of a
delicate dance between intellectual insight and
technological capabilities. It is a synergistic cycle
of advancement where the desire to test a research
hypothesis may motivate the creation of a new
technology, and the new technical capacity yields
unanticipated opportunities for wider discovery.
And one of the most important drivers of new
knowledge is the development of technologies for
viewing biology’s fundamental building blocks: the
atoms and molecules that comprise living cells.
Since late 2020, Jefferson researchers have
been using one of the most powerful devices
for “seeing” molecular structures at the atomic
level: Cryo-Electron Microscopy (Cryo-EM).
The development of Cryo-EM reflects the
convergence of technological skill and biomedical
purpose. And at Jefferson the device will create
opportunities across a broad spectrum—from
basic biology discovery research to applications
in materials science and textile engineering.
“For many years, X-ray crystallography has been
the predominant technique for studying the threedimensional structure of biological macromolecules
in detail,” says Gino Cingolani, PhD, professor and
vice chair of biochemistry and molecular biology and

director of Jefferson’s X-ray crystallography facility.
“But it has limitations: crystallizing macromolecules
is arduous and time-consuming; many proteins
won’t crystallize and the process can alter the
structure, misrepresenting the molecule’s folding.”
Being able to move beyond those limitations is one
of the reasons why Dr. Cingolani is so pleased to be
guiding the University’s newly established Cryo-EM
facility. Cryo-EM has become the state-of-the-art
technology for describing biological complexes
and their mechanisms at their most basic level,” he
explains. “It enables researchers to generate threedimensional images of biomolecules, see how they
function and how they interact with each other.”
In awarding the 2017 Nobel Prize in Chemistry to
the developers of Cryo-EM, the Nobel Committee
said, “This technology has taken biochemistry
into a new era.” In fact, we are benefiting from
that “new era” right now. “The mRNA-based
COVID-19 vaccines created by the PfizerBioNTec, Moderna and others are premised on
an understanding of the novel coronavirus’s
chemical structure,” Dr. Cingolani points out. “It
was Cryo-EM that enabled scientists to define
that structure in just weeks, rather than the years
it would have taken using X-ray crystallography.”

Cryo-EM enables researchers to
generate three-dimensional images of
biomolecules, see how they function and
how they interact with each other.”
Gino Cingolani, PhD

8

Thomas Jefferson University | Jefferson.edu/Research

Jefferson is one of fewer than a
dozen research centers in the eastern
United States with a dedicated CryoEM facility. “This groundbreaking
technology is opening exciting
new research opportunities across
the University,” Dr. Cingolani says.
“It will vastly expand our ability to
understand the mechanisms driving
disease at the cellular, molecular,
and atomic levels. And it will be a
catalyst for development of targeted,
highly effective new treatments
for a wide range of diseases.” 

The Cryo-EM device captures thousands
of two-dimensional images, such as the
image ABOVE. It uses computer algorithms
to integrate them into three-dimensional
visual models of individual and complex
molecules, like the image on the RIGHT.
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